` CLPT (Clearpoint Neuro Inc) vs S&P 500 Comparison - Alpha Spread

CLPT
vs
S&P 500

Over the past 12 months, CLPT has significantly outperformed S&P 500, delivering a return of 172% compared to the S&P 500's 8% growth.

Stocks Performance
CLPT vs S&P 500

Loading
CLPT
S&P 500
Add Stock

Performance Gap
CLPT vs S&P 500

Loading
CLPT
S&P 500
Difference

Performance By Year
CLPT vs S&P 500

Loading
CLPT
S&P 500
Add Stock

Competitors Performance
Clearpoint Neuro Inc vs Peers

Clearpoint Neuro Inc
Glance View

Economic Moat
Narrow
Market Cap
394.7m USD
Industry
Health Care

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 80 full-time employees. The company went IPO on 2019-07-03. The Company’s product platforms include SmartFlow Cannula and ClearPoint Navigation System Software. The SmartFlow Cannula is being utilized in approved combination product clinical and preclinical studies by pharmaceutical companies and academic research customers for various research and clinical trials in connection with delivery of therapeutic agents. The ClearPoint Navigation System Software is a software for surgical planning, navigation to target, and device delivery. The Company’s software and MRI-compatible workstation coordinate with the scanner to effectively utilize intraprocedural MR images. This provides real-time navigational instruction for the neurosurgeon to reach the desired anatomical target with a high degree of precision.

CLPT Intrinsic Value
6.6 USD
Overvaluation 54%
Intrinsic Value
Price
Back to Top